Clearline Capital LP

13F Holdings History for HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX)

Symbol: HRTX on Nasdaq
Investment type: Equity / Common Stock, par value $0.01 per share
Latest Disclosed Ownership: 9.71M shares
Security Ownership: 5.3%

Shares, Excluding Options vs Price

Value, Excluding Options

Clearline Capital LP ownership in HERON THERAPEUTICS, INC. /DE/ Common Stock, par value $0.01 per share (HRTX)

2025-11-26 - Clearline Capital LP has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 9.71M shares of HERON THERAPEUTICS, INC. /DE/ Common Stock, par value $0.01 per share (HRTX). This represents 5.3% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Clearline Capital LP	5.3%		$11.7M	9.71M			$1.20	13G	9/30/2025	26 Nov 2025 10:15:35

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	1.06%	+0.96%	$12.2M	9.71M	+8,855,361	+1033%	$1.26	Q3 2025
6/30/2025	0.16%	-0.04%	$1.77M	857K	-202,745	-19.1%	$2.07	Q2 2025
3/31/2025	0.24%	-0.17%	$2.33M	1.06M	-750,572		$2.20	Q1 2025
12/31/2024	0.37%	-0.08%	$2.77M	1.81M	-416,029	-18.7%	$1.53	Q4 2024
9/30/2024	0.39%	+0.13%	$4.43M	2.23M	+731,246	+48.9%	$1.99	Q3 2024
6/30/2024	0.46%	-0.44%	$5.23M	1.5M	-1,280,938	-46.1%	$3.50	Q2 2024
3/31/2024	0.76%	-1.02%	$7.69M	2.78M	-3,292,350	-54.3%	$2.77	Q1 2024
12/31/2023	1.15%	-0.01%	$10.3M	6.07M	-81,288	-1.32%	$1.70	Q4 2023
9/30/2023	0.54%	+0.31%	$6.33M	6.15M	+3,483,858	+131%	$1.03	Q3 2023
6/30/2023	0.18%	+0.04%	$3.09M	2.67M	+576,692	+27.6%	$1.16	Q2 2023
3/31/2023	0.48%	+0.24%	$3.15M	2.09M	+1,064,510	+104%	$1.51	Q1 2023
12/31/2022	0.46%	+0.46%	$2.56M	1.02M	+1,024,782	NEW	$2.50	Q4 2022
6/30/2020		-0.26%	$0	0	-47,667	-100%		Q2 2020
3/31/2020	0.26%	+0.26%	$560K	47.7K	+47,667	NEW	$11.75	Q1 2020
9/30/2019		-0.15%	$0	0	-16,920	-100%		Q3 2019
6/30/2019	0.15%	-0.2%	$315K	16.9K	-22,416	-57%	$18.62	Q2 2019
3/31/2019	0.5%		$961K	39.3K			$24.43	Q1 2019
12/31/2018	0.7%	+0.15%	$1.02M	39.3K	+8,577	+27.9%	$25.93	Q4 2018
9/30/2018	0.58%	+0.58%	$974K	30.8K	+30,759	NEW	$31.67	Q3 2018

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.